BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6763031)

  • 21. [Penbutolol and propranolol in the treatment of hypertension. A double-blind comparative study in general practice].
    Astvad K; Krogh A; Sidenius J
    Ugeskr Laeger; 1984 Oct; 146(41):3104-6. PubMed ID: 6393504
    [No Abstract]   [Full Text] [Related]  

  • 22. Penbutolol in hypertension: a pilot study with single daily doses.
    Yajnik VH; Nandi JS; Patel SC; Doshi HV; Patel SH
    J Int Med Res; 1977; 5(4):236-42. PubMed ID: 328328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of penbutolol for systemic hypertension. Penbutolol Research Group.
    Schoenberger JA
    Am J Cardiol; 1989 Jun; 63(18):1339-42. PubMed ID: 2658525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.
    Ohman KP; Asplund J; Landahl S; Liander B
    Eur J Clin Pharmacol; 1982; 22(2):95-9. PubMed ID: 7047173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ocular responses of oral administration of penbutolol in the glaucomatous patient.
    Krieglstein GK; Gramer E; Leydhecker W
    Acta Ophthalmol (Copenh); 1980 Aug; 58(4):608-16. PubMed ID: 7010884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
    Yasky J; Verho M; Rangoonwala B
    Curr Med Res Opin; 1987; 10(6):397-406. PubMed ID: 3552458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of the exercise test in the differentiated treatment of patients with hypertension].
    Liusov VA; Bakhshaliev AB; Ibragimov MA
    Klin Med (Mosk); 1988 Oct; 66(10):64-8. PubMed ID: 3236786
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
    van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ["Slow-release" metoprolol in the therapy of hypertension: comparison with divided doses].
    Pirani R; Buzzetti G; Gruppillo P; Padovan G; Masoni C
    Clin Ter; 1981 Sep; 98(6):627-41. PubMed ID: 7026144
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of atenolol and penbutolol in hypertensive patients.
    Lameijer LD; Houtzagers JJ; Voermans LA
    Eur Heart J; 1983 Jul; 4 Suppl D():53-6. PubMed ID: 6352272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease].
    Demin AA; Mitrokhin VE
    Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penbutolol: a new beta blocker in the treatment of moderate essential hypertension.
    Cangiano JL; Ayala JM; Boksay IJ; Martinez-Maldonado M
    J Clin Pharmacol; 1979 Jul; 19(7):384-9. PubMed ID: 479383
    [No Abstract]   [Full Text] [Related]  

  • 33. Longterm treatment of hypertension with penbutolol.
    Kundu SC; Bhattacherjee TD; Banerjee D; Nandi JS
    J Assoc Physicians India; 1984 Jun; 32(6):473-5. PubMed ID: 6511719
    [No Abstract]   [Full Text] [Related]  

  • 34. Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1981 Jul; 22(1):1-25. PubMed ID: 7261952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Circadian blood pressure behavior in hypertensive patients treated with a beta receptor blocker].
    Freude J
    ZFA (Stuttgart); 1983 Mar; 59(8):479-82. PubMed ID: 6134400
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-blockers in hypertensive non-insulin-dependent diabetics: comparison between penbutolol and propranolol on metabolic control and response to insulin-induced hypoglycemia.
    Marengo C; Marena S; Renzetti A; Mossino M; Pagano G
    Acta Diabetol Lat; 1988; 25(2):141-8. PubMed ID: 3066086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyldopa: single daily dose versus multiple daily dose.
    Yang C; Gurwich E; Kanada S; Nascimento L
    Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Time-related effect of betapressin+ in patients with essential hypertension stage II].
    Zaslavskaia RM; Lilitsa GV; Akhmetov KZ; Teiblium MM
    Klin Med (Mosk); 1996; 74(9):43-5. PubMed ID: 9121089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
    Frithz G
    Practitioner; 1982 Mar; 226(1365):562-4. PubMed ID: 7045847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.